Clinical Trials Logo

Injection Site Irritation clinical trials

View clinical trials related to Injection Site Irritation.

Filter by:

NCT ID: NCT03420560 Recruiting - Clinical trials for Temperature Change, Body

A Warmer Temperature Decrease Propofol Injection Pain

Start date: February 28, 2018
Phase: N/A
Study type: Interventional

Propofol injection pain will be surfed by up to 70-80 percentage by the Patients who induced by propofol. Temperature of Operating room was set to a certain range in normal clinical practice, which is 22- 26 centigrade. Warm feeling will make skin vassal dilated and more blood will pass through to bring more heat out of our body. It had been reported that a bigger venous vessels will get less propofol injection pain. The investigators hypothesis that Patients who stayed in a warmer room temperature will surf less injection pain while compare to a normal setting room temperature.

NCT ID: NCT02524743 Completed - Clinical trials for Injection Site Irritation

The Prevention of Pain Associated With Rocuronium Injection

Start date: May 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether efficacy of different doses of lidocain and acetaminophen for the prevention of rocuronium injection pain and frequency of withdrawal movements during the general anesthesia induction period.

NCT ID: NCT01824758 Completed - Clinical trials for Injection Site Irritation

Effect of Esmolol on Pain Due to Rocuronium

Start date: March 2013
Phase: Phase 4
Study type: Interventional

90 American society of anesthesiology (ASA) physical status I and II patients undergoing general anesthesia for elective surgery will be included in the study. Patients will be randomized into three groups. Group E will receive esmolol (1 mg/kg), Group IL lidocaine (0.5 mg/kg)and Group C placebo(NaCl 0.9%, 5 mL), followed by a 0.05 mg/kg rocuronium. After intravenous induction with propofol, adequate muscle relaxation for intubation will be received by 0.5 mg/kg rocuronium.